Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma
In conclusion, TNFRSF21 may act as a novel target for lung cancer chemotherapy, particularly for eradicating lung CSCs.
Authors
- Xiaofeng Tian (ORCID: https://orcid.org/0000-0001-9219-1868)
- Hongying Wang (ORCID: https://orcid.org/0000-0001-8443-3839)
- Haibo Hu (ORCID: https://orcid.org/0000-0003-1851-7756)
- Yiwei Hu
- Haoyang Yuan
- Chuxu Wang
- Koufeng Shao
- Daien Zhou
Institutions
- Kunming University of Science and Technology (CN)
- Xuzhou Medical College (CN)
- Kunming Medical University (CN)
- Second People’s Hospital of Huai’an (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
- Published
- 2024-09-09
- DOI
- https://doi.org/10.32604/or.2024.050182
- Citations
- 1
- Primary Topic
- Cell death mechanisms and regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.23